Abstract
Experimental Autoimmune Encephalomyelitis (EAE) was induced for the evaluation of a new drug candidate (GEM-SP) for multiple sclerosis. Using immunocytochemical techniques with a pan-leukocyte marker, "anti-CD 45", differential leukocyte infiltration was compared in different experimental groups: 1) EAE-immunized rats treated with GEM-SP; 2) EAE-immunized rats treated with NaCl; 3) EAE-immunized rats treated with free constituents (not linked to inert carrier protein) and the inert carrier protein of GEM-SP. The results were conclusive: a very high degree of infiltration was observed in groups 2 and 3. Compared with these, group 1 showed a very poor leukocyte infiltration. Thus, the effect of GEM-SP against leukocyte infiltration was very strong, suggesting a decrease of the blood brain barrier permeability. Moreover, the same composition of GEM-SP (non-linked) was poorly active against leukocyte infiltration. The effect of GEM-SP therefore on the blood brain barrier appears to be very effective, rendering it less permeable to leukocyte infiltration and decreasing leukocyte infiltration per se and/or it is also possible that GEM-SP could play an immunomodulator role. The present results suggest GEM-SP as a new potential drug candidate for the treatment of multiple sclerosis.
Keywords: GEM-SP drug, leukocyte infiltration, experimental autoimmune encephalomyelitis (EAE), blood brain barrier, (BBB), multiple sclerosis (MS), immunohistochemistry, autoimmunity, immunomodulator, pan-leukocyte marker (anti-CD 45)
Letters in Drug Design & Discovery
Title: Evaluation of the Effects of a New Drug on Brain Leukocyte Infiltration in an Experimental Model of Autoimmune Encephalomyelitis
Volume: 3 Issue: 3
Author(s): A. Mangas, R. Covenas, D. Bodet, M. P. Dabadie, G. Glaize and M. Geffard
Affiliation:
Keywords: GEM-SP drug, leukocyte infiltration, experimental autoimmune encephalomyelitis (EAE), blood brain barrier, (BBB), multiple sclerosis (MS), immunohistochemistry, autoimmunity, immunomodulator, pan-leukocyte marker (anti-CD 45)
Abstract: Experimental Autoimmune Encephalomyelitis (EAE) was induced for the evaluation of a new drug candidate (GEM-SP) for multiple sclerosis. Using immunocytochemical techniques with a pan-leukocyte marker, "anti-CD 45", differential leukocyte infiltration was compared in different experimental groups: 1) EAE-immunized rats treated with GEM-SP; 2) EAE-immunized rats treated with NaCl; 3) EAE-immunized rats treated with free constituents (not linked to inert carrier protein) and the inert carrier protein of GEM-SP. The results were conclusive: a very high degree of infiltration was observed in groups 2 and 3. Compared with these, group 1 showed a very poor leukocyte infiltration. Thus, the effect of GEM-SP against leukocyte infiltration was very strong, suggesting a decrease of the blood brain barrier permeability. Moreover, the same composition of GEM-SP (non-linked) was poorly active against leukocyte infiltration. The effect of GEM-SP therefore on the blood brain barrier appears to be very effective, rendering it less permeable to leukocyte infiltration and decreasing leukocyte infiltration per se and/or it is also possible that GEM-SP could play an immunomodulator role. The present results suggest GEM-SP as a new potential drug candidate for the treatment of multiple sclerosis.
Export Options
About this article
Cite this article as:
Mangas A., Covenas R., Bodet D., Dabadie P. M., Glaize G. and Geffard M., Evaluation of the Effects of a New Drug on Brain Leukocyte Infiltration in an Experimental Model of Autoimmune Encephalomyelitis, Letters in Drug Design & Discovery 2006; 3 (3) . https://dx.doi.org/10.2174/157018006776286943
DOI https://dx.doi.org/10.2174/157018006776286943 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of GABAergic Agents on Multiple Sclerosis. A Narrative Review of <i> In-vivo</i> Models
CNS & Neurological Disorders - Drug Targets Skin as a Novel Route for Allergen-specific Immunotherapy
Current Pharmaceutical Design Experimental Autoimmune Encephalomyelitis (EAE) Model of Cynomolgus Macaques Induced by Recombinant Human MOG1-125 (rhMOG1-125) Protein and MOG34-56 Peptide
Protein & Peptide Letters Targeting Angiotensin-converting Enzyme 2 (ACE2) for the Discovery of Anticoronaviral Drugs
Coronaviruses Tetramethoxyluteolin for the Treatment of Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator
Endocrine, Metabolic & Immune Disorders - Drug Targets BAFFling Autoimmune Disorders and Helicobacter pylori Disease: The Interplay between BAFF and the Th17 Response
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Cosignaling Molecules Around LIGHT-HVEM-BTLA: From Immune Activation to Therapeutic Targeting
Current Molecular Medicine “Metabolic Aspects” In Inflammatory Bowel Diseases
Current Drug Delivery Progress in the Oral Treatment of Type 2 Diabetes: Update on DPP-IV Inhibitors
Current Diabetes Reviews Vitamin-D in the Immune System: Genomic and Non-Genomic Actions
Mini-Reviews in Medicinal Chemistry Allergen-Specific Responses of CD19high and CD19low B Cells in Non-IgEMediated Food Allergy of Late Eczematous Reactions in Atopic Dermatitis: Presence of IL-17- and IL-32-Producing Regulatory B Cells (Br17 & Br32)
Inflammation & Allergy - Drug Targets (Discontinued) Identification of Essential cis Element in 5'UTR of Nef mRNA for Nef Translation
Current HIV Research Advances in the Immune Pathogenesis and Treatment of Multiple Sclerosis
Central Nervous System Agents in Medicinal Chemistry Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Pharmacological Perspectives of Wasp Venom
Protein & Peptide Letters NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation
Current Immunology Reviews (Discontinued) The Contribution of Proteinase-Activated Receptors to Intracellular Signaling, Transcellular Transport and Autophagy in Alzheimer´s Disease
Current Alzheimer Research Organotypic Cultures as Tool to Test Long-Term Effects of Chemicals on the Nervous System
Current Medicinal Chemistry The Extracellular Matrix of Blood Vessels
Current Pharmaceutical Design